// App-Quantinova.ai

S141 : ELICITING ANTI-TUMOR T CELL ACTIVITY IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH BISPECIFIC ANTIBODY-BASED COMBINATION THERAPY

Researchers

Presenter

  • Despoina Papazoglou

Principal Investigators

  • Loic Ysebaert

  • Nikolaos Ioannou

  • Benedetta Apollonio

  • Piers Patten

  • Sylvia Herter

  • Marina Bacac

  • Alexander Deutsch

  • Christian Klein

  • Anna Vardi

  • Anne Quillet-Mary

  • Alan Ramsay

Medical Centers

  • Roche Innovation Center Zurich,Roche

  • Medical University of Graz,Graz,Австрия

  • Medical University Graz, Graz, Austria

  • Medical University Graz, Graz, Austria

  • Hemato-oncology,King's College London,London,United Kingdom

  • Centre de Recherche en Cancerologie de Toulouse, CRCT, Toulouse, France

  • Roche Innovation Center Zurich,Roche Pharma Research and Early Development,Zurich,Schweiz

  • Hematology Department/ BMT unit, G.Papanicolaou General Hospital, Thessaloniki, Greece

  • Roche Innovation Center Zurich,Roche Pharma Research and Early Development,Zurich,Schweiz

  • Medical University Graz, Graz, Austria

  • Hemato-oncology,King's College London,London,United Kingdom

  • Hemato-oncology,King's College London,London,Vereinigtes Königreich

  • Roche Innovation Center Zurich,Roche Pharma Research and Early Development,Zurich,Schweiz

  • Hematology Department/ BMT unit, G.Papanicolaou General Hospital, Thessaloniki, Greece

  • Roche Innovation Center Zurich,Roche Pharma Research and Early Development,Zurich,Schweiz

  • Hematology Department/ BMT unit, G.Papanicolaou General Hospital, Thessaloniki, Greece

  • Hematology Department/ BMT unit, G.Papanicolaou General Hospital, Thessaloniki, Greece

  • Centre de Recherche en Cancerologie de Toulouse, CRCT, Toulouse, France

  • Medical University Graz, Graz, Austria

  • Medical University Graz, Graz, Austria

  • Hemato-oncology,King's College London,London,United Kingdom

  • Hemato-oncology,King's College Londo

  • King's Health Partners,King's College Hospital,London,Vereinigtes Königreich

  • Centre de Recherche en Cancerologie de Toulouse, CRCT, Toulouse, France

  • Medical University Graz, Graz, Austria

  • Hematology Department/ BMT unit, G.Papanicolaou General Hospital, Thessaloniki, Greece

  • Centre de Recherche en Cancerologie de Toulouse, CRCT, Toulouse, France

  • Hemato-oncology,King's College London,London,Vereinigtes Königreich

  • Hemato-oncology,King's College London,London,United Kingdom

Locations

  • United Kingdom

  • France

  • Switzerland

  • Austria

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved